Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

A common genetic mechanism in malignant bone marrow diseases.

Levine RL, Carroll M.

N Engl J Med. 2009 May 28;360(22):2355-7. doi: 10.1056/NEJMe0902257. No abstract available.

PMID:
19474434
[PubMed - indexed for MEDLINE]
2.

Mutation in TET2 in myeloid cancers.

Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F, Alberdi A, Lécluse Y, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Viguié F, Fontenay M, Vainchenker W, Bernard OA.

N Engl J Med. 2009 May 28;360(22):2289-301. doi: 10.1056/NEJMoa0810069.

PMID:
19474426
[PubMed - indexed for MEDLINE]
Free Article
3.

[Mutations in TET2 in myeloid cancers].

Bernard OA, Delhommeau F, Fontenay M, Vainchenker W.

Med Sci (Paris). 2009 Oct;25(10):785-8. doi: 10.1051/medsci/20092510785. French. No abstract available.

PMID:
19849974
[PubMed - indexed for MEDLINE]
Free Article
4.

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms.

Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B, Hunault-Berger M, Slama B, Vey N, Lacombe C, Solary E, Birnbaum D, Bernard OA, Fontenay M.

Leukemia. 2010 May;24(5):1094-6. doi: 10.1038/leu.2010.52. Epub 2010 Apr 8. No abstract available.

PMID:
20376084
[PubMed - indexed for MEDLINE]
5.

[Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].

Kreipe HH.

Pathologe. 2011 Nov;32 Suppl 2:271-6. doi: 10.1007/s00292-011-1504-5. Review. German.

PMID:
22033685
[PubMed - indexed for MEDLINE]
6.

Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.

Couronné L, Lippert E, Andrieux J, Kosmider O, Radford-Weiss I, Penther D, Dastugue N, Mugneret F, Lafage M, Gachard N, Nadal N, Bernard OA, Nguyen-Khac F.

Leukemia. 2010 Jan;24(1):201-3. doi: 10.1038/leu.2009.169. Epub 2009 Aug 27. No abstract available.

PMID:
19710701
[PubMed - indexed for MEDLINE]
7.

A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.

Euba B, Vizmanos JL, García-Granero M, Aranaz P, Hurtado C, Migueliz I, Novo FJ, García-Delgado M.

Leuk Lymphoma. 2012 Jun;53(6):1230-3. doi: 10.3109/10428194.2011.639878. Epub 2012 Apr 2. No abstract available.

PMID:
22080757
[PubMed - indexed for MEDLINE]
8.

Gene mutations, epigenetic dysregulation, and personalized therapy in myeloid neoplasia: are we there yet?

Odenike O, Thirman MJ, Artz AS, Godley LA, Larson RA, Stock W.

Semin Oncol. 2011 Apr;38(2):196-214. doi: 10.1053/j.seminoncol.2011.01.010. Review.

PMID:
21421110
[PubMed - indexed for MEDLINE]
9.

Mutation in TET2 in myeloid cancers.

Tefferi A, Lim KH, Levine R.

N Engl J Med. 2009 Sep 10;361(11):1117; author reply 1117-8. doi: 10.1056/NEJMc091348. No abstract available.

PMID:
19741235
[PubMed - indexed for MEDLINE]
Free Article
10.

Significance of JAK2 and TET2 mutations in myelodysplastic syndromes.

Hellström-Lindberg E.

Blood Rev. 2010 Mar;24(2):83-90. doi: 10.1016/j.blre.2010.01.002. Epub 2010 Feb 19. Review.

PMID:
20171768
[PubMed - indexed for MEDLINE]
11.

[Molecular biology and new drug therapy for myeloproliferative neoplasm].

Kitanaka A, Shide K, Shimoda K.

Rinsho Ketsueki. 2013 Oct;54(10):1697-703. Review. Japanese. No abstract available.

PMID:
24064819
[PubMed - indexed for MEDLINE]
12.

[Mutation of tet2 gene and malignant blood disease].

Qian XF, Shen YF, Zhang SJ, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1096-100. Review. Chinese.

PMID:
20723337
[PubMed - indexed for MEDLINE]
13.

The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

Hsieh PP, Olsen RJ, O'Malley DP, Konoplev SN, Hussong JW, Dunphy CH, Perkins SL, Cheng L, Lin P, Chang CC.

Mod Pathol. 2007 Sep;20(9):929-35. Epub 2007 Jul 20.

PMID:
17643100
[PubMed - indexed for MEDLINE]
Free Article
14.

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.

Jankowska AM, Szpurka H, Tiu RV, Makishima H, Afable M, Huh J, O'Keefe CL, Ganetzky R, McDevitt MA, Maciejewski JP.

Blood. 2009 Jun 18;113(25):6403-10. doi: 10.1182/blood-2009-02-205690. Epub 2009 Apr 16.

PMID:
19372255
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.

Janssen JW, Steenvoorden AC, Lyons J, Anger B, Böhlke JU, Bos JL, Seliger H, Bartram CR.

Proc Natl Acad Sci U S A. 1987 Dec;84(24):9228-32.

PMID:
3122217
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cytogenetic correlates of TET2 mutations in 199 patients with myeloproliferative neoplasms.

Hussein K, Abdel-Wahab O, Lasho TL, Van Dyke DL, Levine RL, Hanson CA, Pardanani A, Tefferi A.

Am J Hematol. 2010 Jan;85(1):81-3. doi: 10.1002/ajh.21562. No abstract available.

PMID:
19957346
[PubMed - indexed for MEDLINE]
17.

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features.

Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S, Liu Q, Zhao W, Mehdi M, Galili N, Woda B, Raza A.

Leukemia. 2006 Sep;20(9):1641-4. Epub 2006 Jul 27. No abstract available.

PMID:
16871284
[PubMed - indexed for MEDLINE]
18.

Genetic and epigenetic alterations of myeloproliferative disorders.

Milosevic JD, Kralovics R.

Int J Hematol. 2013 Feb;97(2):183-97. doi: 10.1007/s12185-012-1235-2. Epub 2012 Dec 12. Review.

PMID:
23233154
[PubMed - indexed for MEDLINE]
19.

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis.

Kremer M, Horn T, Dechow T, Tzankov A, Quintanilla-Martínez L, Fend F.

Leukemia. 2006 Jul;20(7):1315-6. Epub 2006 Apr 13. No abstract available.

PMID:
16617316
[PubMed - indexed for MEDLINE]
20.

JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study.

Rinaldi CR, Rinaldi P, Gemei M, Grimaldi F, Battipaglia G, Del Vecchio L, Martino B, Specchia G, Candoni A, Gugliotta L, Vannucchi AM, Barbui T, Pane F.

Am J Hematol. 2010 May;85(5):383-6. doi: 10.1002/ajh.21687. No abstract available.

PMID:
20425802
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk